Normacurve: A supercurve-based method that simultaneously quantifies and normalizes reverse phase protein array data

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Troncale, Sylvie ^a,b,c   Barbet, Aurélie ^a   Coulibaly, Lamine ^a   Henry, Emilie ^a   He, Beilei ^a   Barillot, Emmanuel ^a   Dubois, Thierry ^a   Hupé, Philippe ^a,b,c,d   de Koning, Leanne ^a  

^a INSTITUT CURIE   (France)

^b INSERM U900   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CHECKPOINT KINASE 2;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL DIVISION; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE; HUMAN; HUMAN CELL; INFORMATION PROCESSING; MOUSE; NONHUMAN; NORMACURVE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; REVERSE PHASE PROTEIN ARRAY;

ALGORITHMS; ANIMALS; BREAST; BREAST NEOPLASMS; CATTLE; CELLS, CULTURED; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; INDICATOR DILUTION TECHNIQUES; JURKAT CELLS; MICE; MODELS, THEORETICAL; NIH 3T3 CELLS; PROTEIN ARRAY ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; SERUM ALBUMIN, BOVINE;

EID: 84863010016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038686     Document Type: Article

References (25)

1. Spurrier B, Ramalingam S, Nishizuka S, (2008) Reverse-phase protein lysate microarrays for cell signaling analysis. Nature Protocols 3: 1796-808.
2. Paweletz C, Charboneau L, Bichsel V, Simone N, Chen T, et al. (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20: 1981-9.
3. Wingren C, Borrebaeck C, (2006) Antibody microarrays: current status and key technological advances. OMICS.
4. Wulfkuhle J, Edmiston K, Liotta L, Petricoin E, (2006) Technology insight: pharmacoproteomics for cancer-promises of patient-tailored medicine using protein microarrays. Nature Clinical Practice Oncology 3: 256-68.
5. Speer R, Wulfkuhle J, Espina V, Aurajo R, Edmiston K, et al. (2007) Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy. Cancer Genomics Proteomics 4: 157-64.
6. Creighton C, Fu X, Hennessy B, Casa A, Zhang Y, et al. (2010) Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer. Breast cancer research 12.
7. Marty B, Maire V, Gravier E, Rigaill G, Vincent-Salomon A, et al. (2008) Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells. Breast Cancer Research 10.
8. Davies M, Stemke-Hale K, Lin E, Tellez C, Deng W, et al. (2009) Integrated molecular and clinical analysis of AKT activation in metastatic melanoma. Clinical Cancer Research 15: 7538-7546.
9. Carey MS, Argawal R, Gilks B, Swenerton K, Kalloger S, et al. (2010) Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy. Clinical Cancer Research 16: 2852-60.
10. Tsavachidou-Fenner D, Tannir N, Tamboli P, Liu W, Petillo D, et al. (2010) Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma. Annals of Oncology 21: 1599-606.
11. Pierobon M, Calvert V, Belluco C, Garaci E, Deng J, et al. (2009) Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarker. Clinical Colorectal Cancer 8: 110-7.
12. Mircean C, Shmulevich I, Cogdell D, Choi W, Jia Y, et al. (2005) Robust estimation of protein expression ratios with lysate microarray technology. Bioinformatics 21: 1935-1942.
13. Tibes R, Qiu Y, Lu Y, (2006) Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic. Moleculat Cancer Therapeutics 5: 2512-2521.
14. Tabus I, Hategan A, Mircean C, Rissanen J, Shmulevich I, et al. (2006) Nonlinear modeling of protein expressions in protein arrays. In: IEEE Transactions on signal processing. volume 54.
15. Hu J, He X, Baggerly K, Coombes K, Hennessy B, et al. (2007) Non-parametric quantification of protein lysate arrays. Bioinformatics 23: 1986-1994.
16. Coombes K, Neeley S, Joy C, Hu J, Baggerly K, et al. (2009) Package SuperCurve version 1.3.3.
17. Zhang L, Wei Q, Liu W, Mills G, Coombes K, (2009) Serial dilution curve: a new method for analysis of reverse phase protein array data. Bioinformatics 25: 650-654.
18. Dupuy L, Gauthier C, Durand G, Musnier A, Heitzler D, et al. (2009) A highly sensitive nearinfrared uorescent detection method to analyze signalling pathways by reverse-phase protein array. Proteomics 24: 5446-54.
19. Hennessy B, Lu Y, Gonzalez-Angulo A, Carey M, Myhre S, et al. (2010) A technical assessment of the utility of reverse phase protein array for the study of the functional proteome in nonmicrodissected human breast cancers. Clin Proteomics.
20. Neeley E, Kornblau S, Coombes KR, Baggerly KA, (2009) Variable slope normalization of reverse phase protein arrays. Bioinformatics.
21. Anderson T, Wulfkuhle J, Liotta L, Winslow RL, Petricoin E, (2009) Improved reproducibility of reverse-phase protein microarrays using array microenvironment normalization. Proteomics 9: 5562-5566.
22. Wood S, (2009) Package mgcv.
23. Pinheiro J, Bates D, (2000) Mixed-Effects Models in S and S-PLUS. Springer.
24. Neuvial P, Hupé P, Brito I, Liva S, Manié E, et al. (2006) Spatial normalization of array-CGH data. BMC Bioinformatics 7: 264.
25. Sabbah C, Mazo G, Paccard C, Reyal F, Hupé P, (2011) SMETHILLIUM: spatial normalization method for illumina infinium humanmethylation beadchip. Bioinformatics 27: 1693-1695.